









Markets
/
Stocks
/
nasdaq-asbp
/

Aspire Biopharma Holdings Inc

ASBP

0.098USD

-0.003-2.69%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

4.83MMarket Cap

LossP/E TTM



Aspire Biopharma Holdings Inc

0.098

-0.003-2.69%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Aspire Biopharma Holdings Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q3

FY2021Q2

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-4427.98%-1.10M

-92.52%-1.14M

22.50%-1.75M

594.55%772.12K

120.42%25.50K

-211.83%-592.32K

-1141.02%-2.26M

-335.26%-156.13K

-167.94%-124.92K

-395.04%-189.95K

85.86%-182.11K

---35.87K

74.36%-46.62K

-4093.55%-38.37K

---1.29M

---181.81K

---915.00

Net income from continuing operations

-244.59%-1.85M

-228.98%-1.98M

-546.16%-15.94M

-5818.04%-8.93M

-675.39%-537.02K

-133.24%-602.26K

-185.89%-2.47M

-106.77%-150.91K

-106.43%-69.26K

1401.17%1.81M

3370.60%2.87M

--2.23M

7136.03%1.08M

5164.79%120.69K

---87.83K

---15.31K

---2.38K

Other non-cash items

--2.02M

--364.11K

----

Change in working capital

-46.70%318.36K

-1101.67%-340.42K

-226.15%-326.30K

-16.29%206.33K

198.94%597.34K

-128.82%-28.33K

81.56%258.65K

-11.39%246.49K

-4.22%199.82K

-62.12%98.30K

112.09%142.46K

--278.16K

225.31%208.63K

17574.93%259.47K

---1.18M

---166.50K

--1.47K

-Change in receivables

325.73%1.03M

100.00%0.00

---1.03M

--21.97K

--241.45K

---299.92K

----

-Change in inventory

---35.44K

----

-Change in prepaid expenses

5695.25%363.77K

-829.05%-164.22K

-2590.19%-389.62K

-84.04%27.44K

-96.26%6.28K

-86.78%22.52K

-82.49%15.65K

5.09%171.86K

0.88%167.86K

3.40%170.36K

107.60%89.36K

--163.54K

--166.40K

--164.76K

---1.18M

----

-Change in payables and accrued expense

----

166.51%126.93K

11684.99%319.61K

314.63%219.07K

822.18%213.00K

-43.72%47.63K

-77.84%2.71K

-257.73%-102.06K

164.10%23.10K

--84.62K

--12.24K

--64.71K

---36.03K

----

-Change in other current assets

----

--0.00

100.00%0.00

----

---167.00K

---782.00

-Change in other current liabilities

-100.00%0.00

-470.09%-111.03K

11.10%30.00K

2.57%30.00K

0.00%30.00K

-9.99%27.00K

-2.51%29.25K

0.00%30.00K

-8.23%30.00K

--30.00K

--32.69K

----

Cash from non-recurring investing activities

Cash from operating activities

-4427.98%-1.10M

-92.52%-1.14M

22.50%-1.75M

594.55%772.12K

120.42%25.50K

-211.83%-592.32K

-1141.02%-2.26M

-335.26%-156.13K

-167.94%-124.92K

-395.04%-189.95K

85.86%-182.11K

---35.87K

74.36%-46.62K

-4093.55%-38.37K

---1.29M

---181.81K

---915.00

Investing cash flow

Net cash flow from other investing activities

----

--0.00

-100.00%0.00

-95.15%13.78M

----

--0.00

--632.97K

--284.28M

100.00%0.00

--0.00

---294.69M

----

Cash from non-current investing activities

Net cash flow from investing activities

----

--0.00

-100.00%0.00

-95.15%13.78M

----

--0.00

--632.97K

--284.28M

100.00%0.00

--0.00

---294.69M

----

Financing cash flow

Cash flow from continuous financing activities

11258.43%2.85M

100.00%0.00

36.92%3.09M

-595.43%-772.12K

95.97%-25.50K

95.36%-13.19M

--2.26M

--155.85K

---632.97K

---284.28M

-100.00%0.00

--0.00

-100.00%0.00

--296.59M

--181.81K

--915.00

Net cash flow from debt Issuance/repayment

14816.70%3.75M

-100.00%0.00

1072.02%3.09M

-595.43%-772.12K

---25.50K

--2.59M

--264.03K

--155.85K

----

100.00%0.00

--0.00

-100.00%0.00

---252.91K

--181.81K

--915.00

Net cash flow from common stock issuance/repurchase

----

--0.00

100.00%0.00

---13.78M

----

--0.00

---632.97K

----

Net cash flow from other financing activities

---907.50K

----

---2.00M

--2.00M

--0.00

----

-100.00%0.00

--0.00

--296.85M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

11258.43%2.85M

100.00%0.00

36.92%3.09M

-595.43%-772.12K

95.97%-25.50K

95.36%-13.19M

--2.26M

--155.85K

---632.97K

---284.28M

-100.00%0.00

--0.00

-100.00%0.00

--296.59M

--181.81K

--915.00

Net cash flow

Beginning cash balance

--206.23K

--1.35M

--3.63K

-100.00%0.00

-99.95%280.00

-78.40%125.20K

-49.01%315.15K

--497.26K

--533.13K

--579.75K

--618.12K

--0.00

Current period cash flow changes

--1.74M

---1.14M

--1.34M

100.00%0.00

99.22%-280.00

-167.94%-124.92K

-395.04%-189.95K

-129.46%-182.11K

---35.87K

---46.62K

---38.37K

--618.12K

--0.00

Ending cash balance

--1.95M

--206.23K

--1.35M

--0.00

-100.00%0.00

-99.95%280.00

-78.40%125.20K

-49.01%315.15K

--497.26K

--533.13K

--579.75K

--618.12K

--0.00

Free cash flow

----

594.55%772.12K

120.42%25.50K

-211.83%-592.32K

----

-335.26%-156.13K

-167.94%-124.92K

-395.04%-189.95K

85.86%-182.11K

---35.87K

---46.62K

---38.37K

---1.29M

----

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

